Systems-level Identification of Tinospora cordifolia Constituents as CXCR4-targeting Anti-metastatic Agents
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Metastasis is the leading cause of cancer-related mortality and is regulated by complex processes, including epithelial-mesenchymal transition, invasion, and colonisation. The chemokine receptor CXCR4, interacting with its ligand CXCL12, plays a pivotal role in tumour progression and organ-specific metastasis. Current synthetic CXCR4 inhibitors, such as AMD3100, face limitations due to toxicity, cost, and resistance, highlighting the need for safer alternatives. T. cordifolia, a medicinal plant rich in bioactive phytochemicals, has demonstrated immunomodulatory and anticancer properties but remains unexplored in CXCR4-targeted anti-metastatic therapy. Aim: This study aimed to investigate the anti-metastatic potential of eighteen phytochemicals from Tinospora cordifolia against CXCR4 (PDB ID: 3ODU) using integrated in silico and in vitro approaches. Methods: Phytochemicals were retrieved from the IMPPAT database, and Protein-Protein Interaction (PPI) analysis was performed using STRING to validate the role of CXCR4 in metastasis. Molecular docking (AutoDock Vina) evaluated ligand-receptor interactions. Drug-likeness was assessed via Lipinski’s Rule of Five, and pharmacokinetic profiling was carried out using ADME predictors. Cytotoxicity was evaluated by MTT assay against CXCR4-positive MDA-MB-231 and HEK293 cells. Results: MTT assays revealed a non-toxic window up to 10 µM for all compounds, with tumour-selective effects of kaempferol and β-sitosterol at higher concentrations. Docking scores ranged from -6.5 to -9.5 kcal/mol, with beta-sitosterol (-9.5 kcal/mol), tinosporaside (-9.1 kcal/mol), and malabarolide (-8.7 kcal/mol) showing the strongest interactions, stabilising via hydrophobic and hydrogen bonding with key CXCR4 residues. Fourteen compounds met drug-likeness criteria, and seven lead molecules demonstrated optimal ADME properties, including non-BBB permeability, high GI absorption, and minimal CYP450 interactions. The seven identified lead compounds were beta-sitosterol, tinosporaside, malabarolide, kaempferol, chasmanthin, palmarin, and syringin. Conclusion: Phytochemicals from T. cordifolia demonstrate strong potential as CXCR4 inhibitors, with beta-sitosterol, kaempferol, and tinosporaside emerging as lead candidates. Their favorable binding profiles and pharmacokinetic properties suggest promising translational value as anti-metastatic agents. Further experimental validation in migration assays, receptor-binding studies, and animal models is warranted to confirm efficacy and safety. Major Findings: Seven phytochemicals from T. cordifolia showed strong binding affinity toward CXCR4 (-8.0 to -9.5 kcal/ mol), with β-sitosterol emerging as the top candidate, demonstrating stable hydrogen bonding and hydrophobic interactions within the binding pocket. Fourteen compounds met Lipinski’s criteria, seven exhibited favourable ADME profiles, and MTT assays confirmed a non-toxic window up to 10 µM with tumour-selective cytotoxicity at higher concentrations, supporting their potential as CXCR4-targeted natural anti-metastatic leads.
Fields of Study & Subjects
Computational Drug Discovery Methods
Chemokine receptors and signaling
Medicinal Plant Research
Publication details
- Journal / source
- Journal of Natural Remedies
- Pages
- 713–722
- Publication date
- 31 March 2026
- Language
- EN